HIP310 details

HIPidHIP310
SequenceISSEVHIPLGDARLV
Length15
Nomenclaturevif 51-65
Sourcevif
Cell line NA
Inhibition/IC50  39.4
Unit %
TargetProtease inhibition
AssayHPLC
PropertiesView
StructureJmol
PaperPeptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
AuthorsFriedler A, Blumenzweig I, Baraz L, Steinitz M, Kotler M, Gilon C.
ReferenceJ Mol Biol. 1999 Mar 19;287(1):93-101.
Pubmed ID10074409

 CSIR-Institute of Microbial Technology, Chandigarh 160036, India